1. ScholarBank@NUS

Pei Shi Ong

rp10093

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Pei Shi Ong
Variants
Ong, P.S.
Ong, P.-S.
 
Main Affiliation
 
Faculty
 
Email
phaops@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Department:  PHARMACY AND PHARMACEUTICAL SCIENCES
Policy:  Open

Results 1-11 of 11 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
12018A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugsWong, A.L.-A ; Xiang, X; Ong, P.S ; Mitchell, E.Q.Y; Syn, N; Wee, I; Kumar, A.P ; Yong, W.P ; Sethi, G ; Goh, B.C ; Ho, P.C.-L ; Wang, L 
22018Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in singapore: A qualitative studyKoh, J.J.K. ; Cheng, R.X.; Yap, Y.; Haldane, V. ; Tan, Y.G.; Teo, K.W.Q.; Srivastava, A. ; Ong, P.S. ; Perel, P.; Legido-Quigley, H. 
32016Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentWang, L ; Khoa Phan, D.D; Zhang, J; Ong, P.-S ; Thuya, W.L ; Soo, R.A ; Wong, A.L.-A ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
427-Jul-2012Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcomeHoskins, J.M.; Ong, P.-S. ; Keku, T.O.; Galanko, J.A.; Martin, C.F.; Coleman, C.A.; Wolfe, M.; Sandler, R.S.; McLeod, H.L.
52016Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectivesOng, P.S ; Wang, L.Z; Dai, X; Tseng, S.H; Loo, S.J; Sethi, G 
62019Perspectives on acceptance and use of a mobile health intervention for the prevention of atherosclerotic cardiovascular disease in singapore: mixed-methods studyHaldane, V.; Tan, Y.G.; Teo, K.W.Q.; Koh, J.J.; Srivastava, A.; Cheng, R.X.; Yap, Y.C.; Ong, P.-S. ; van Dam, R.M.; Foo, J.M.; Müller-Riemenschneider, F.; Koh, G.C.-H.; Perel, P.; Legido-Quigley, H.
718-Jul-2021Prescribing patterns, efficacy and safety of DOAC usage in a tertiary hospitalYong, Kar Ying; Leow, Shirlene; Yap, Eng Soon; Ong, Pei Shi ; Tan, Su Ching ; Goh, Pik Wei
82014Quantification of the resveratrol analogs trans-2,3-dimethoxystilbene and trans-3,4-dimethoxystilbene in rat plasma: Application to pre-clinical pharmacokinetic studiesNg, S.Y; Cardullo, N; Yeo, S.C.M; Spatafora, C; Tringali, C; Ong, P.-S ; Lin, H.-S 
91-Sep-2021Resveratrol for cancer therapy: Challenges and future perspectivesRen, Boxu; Kwah, Marabeth Xin-Yi; Liu, Cuiliu; Ma, Zhaowu; Shanmugam, Muthu K. ; Ding, Lingwen ; Xiang, Xiaoqiang; Ho, Paul Chi-Lui ; Wang, Lingzhi ; Ong, Pei Shi ; Goh, Boon Cher 
1020-Sep-2018Safety and Effectiveness of Azathioprine in Patients with Inflammatory Bowel Disease (IBD) in SingaporeFoo, Elston; Gan, Jia-min; Ong, Wan-chee; Chan, Webber ; Shim, Hang-hock ; Ong, Pei-Shi ; Lim, Teong-Guan 
112019User preferences and persona design for an mhealth intervention to support adherence to cardiovascular disease medication in singapore: A multi-method studyHaldane, V.; Koh, J.J.K. ; Srivastava, A. ; Teo, K.W.Q.; Tan, Y.G.; Cheng, R.X.; Yap, Y.C.; Ong, P.-S. ; van Dam, R.M. ; Foo, J.M. ; Müller-Riemenschneider, F. ; Koh, G.C.-H. ; Foong, P.S. ; Perel, P.; Legido-Quigley, H.